Aeromonas hydrophila in Aquaculture: Pathogenicity, Diagnostics, and Vaccine Development

Introduction

Aeromonas hydrophila is a Gram-negative, facultatively anaerobic, rod-shaped bacterium belonging to the family Aeromonadaceae. It is a ubiquitous inhabitant of freshwater and brackish environments and is a primary etiological agent of motile aeromonad septicemia (MAS) in a wide range of cultured fish species, including cyprinids, cichlids, salmonids, and catfish [1, 2]. Outbreaks of MAS cause substantial economic losses in global aquaculture due to high mortality rates, reduced growth performance, and increased treatment costs [3]. The pathogen is also implicated in coinfections with other aquatic pathogens, such as those described in Streptococcosis in Farmed Tilapia and Mycobacterium marinum Infections in Aquatic Animals. This review provides an exhaustive examination of A. hydrophila pathogenicity, diagnostic methodologies, and vaccine development strategies, with emphasis on autogenous approaches.

Pathogenicity and Virulence Factors

Motile Aeromonad Septicemia

MAS is a hemorrhagic septicemic disease characterized by exophthalmia, cutaneous ulcers, fin rot, ascites, and necrosis of internal organs [4]. The pathogenesis involves bacterial adhesion, invasion, and evasion of host immune responses. A. hydrophila produces a diverse arsenal of virulence factors that facilitate these processes.

Key Virulence Determinants

The major virulence factors of A. hydrophila are summarized in Table 1.

Table 1. Major Virulence Factors of Aeromonas hydrophila

The T3SS is particularly critical for virulence. It is encoded on a pathogenicity island and is regulated by environmental signals such as temperature, pH, and calcium concentration [13]. Effector proteins delivered by T3SS inhibit phagocytosis, modulate apoptosis, and disrupt cytoskeletal dynamics [14].

Quorum Sensing and Regulation

A. hydrophila employs N-acyl homoserine lactone (AHL)-based quorum sensing (QS) systems, including the AhyI/AhyR system, to coordinate virulence gene expression [15]. QS regulates biofilm formation, protease production, and aerolysin synthesis. Disruption of QS has been explored as an antivirulence strategy [16].

Diagnostic Approaches

Accurate and timely diagnosis of A. hydrophila infection is essential for disease management. Diagnostic methods range from conventional culture to advanced molecular and serological techniques.

Conventional Bacteriology

Isolation of A. hydrophila from kidney, spleen, or skin lesions is performed on selective media such as Rimler-Shotts agar or Aeromonas selective agar supplemented with ampicillin [17]. Colonies appear yellow on starch-ampicillin agar due to amylase activity. Biochemical identification relies on oxidase positivity, resistance to vibriostatic agent O/129, and fermentation of glucose, sucrose, and mannitol [18]. Commercial biochemical test strips are available but may misidentify atypical strains [19].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting species-specific genes (e.g., 16S rRNA, gyrB, rpoD) and virulence genes (aerA, hlyA, act, alt, ast) are widely used [20, 21]. Multiplex PCR panels can simultaneously detect A. hydrophila and other aquatic pathogens, such as those involved in Streptococcus iniae and Lactococcus garvieae Infections. Quantitative real-time PCR (qPCR) provides quantification of bacterial load and is useful for monitoring subclinical infections [22].

Loop-mediated isothermal amplification (LAMP) assays offer rapid, field-deployable detection with high sensitivity and specificity, targeting the gyrB or aerA genes [23]. LAMP does not require thermal cycling and can be read by colorimetric indicators.

Serological Methods

Enzyme-linked immunosorbent assay (ELISA) using polyclonal or monoclonal antibodies against A. hydrophila LPS or outer membrane proteins (OMPs) can detect bacterial antigens in tissue homogenates or water samples [24]. The principles are analogous to those described for Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus. However, cross-reactivity with other Aeromonas species limits specificity [25].

Diagnostic Workflow

The following Mermaid diagram illustrates a recommended diagnostic algorithm for A. hydrophila in aquaculture.

flowchart TD
    A[Fish with clinical signs: hemorrhages, exophthalmia, ulcers], > B{Sampling}
    B, > C[Kidney/spleen swab or tissue]
    B, > D[Water or biofilm sample]
    C, > E[Culture on selective agar]
    E, > F[Biochemical identification]
    F, > G[PCR for species confirmation]
    G, > H[Virulence gene profiling]
    D, > I[Concentration/filtration]
    I, > J[DNA extraction]
    J, > K[qPCR or LAMP]
    K, > L[Quantification and risk assessment]
    H, > M[Antimicrobial susceptibility testing]
    M, > N[Therapeutic decision]
    L, > N

Vaccine Development

Vaccination is a cornerstone of sustainable disease control in aquaculture. Several vaccine platforms have been evaluated against A. hydrophila, including inactivated whole-cell vaccines, live attenuated vaccines, subunit vaccines, and DNA vaccines. Autogenous vaccines, prepared from farm-specific isolates, are increasingly used due to antigenic diversity among strains [26].

Inactivated Vaccines

Formalin-killed whole-cell bacterins are the most common commercial products. They are administered by immersion or injection and induce humoral immunity, primarily against LPS and OMPs [27]. Protection levels vary, and booster doses are often required [28]. Oil-adjuvanted bacterins enhance antibody titers but may cause injection-site reactions [29].

Live Attenuated Vaccines

Attenuated strains with deletions in virulence genes (e.g., aroA, aerA, or T3SS components) have shown promise in experimental trials [30]. These vaccines stimulate both humoral and cell-mediated immunity and can be delivered orally via feed [31]. Safety concerns regarding reversion to virulence and environmental shedding require rigorous evaluation [32].

Subunit and Recombinant Vaccines

Recombinant OMPs (e.g., OmpA, OmpW, Omp48) and flagellin (Fla) have been tested as subunit vaccines [33, 34]. They are produced in Escherichia coli expression systems and purified for injection. Immunization with recombinant OmpA induced high antibody titers and reduced mortality in challenged carp [35]. DNA vaccines encoding aerolysin or OMP genes have also been developed, but delivery efficiency remains a challenge [36].

Autogenous Vaccine Approach

Autogenous vaccines are custom-prepared from bacterial isolates recovered from the affected farm. The process involves:

1. Isolation and identification of the dominant A. hydrophila strain.
2. Confirmation of virulence gene profile and serogroup.
3. Inactivation with formalin or binary ethylenimine.
4. Formulation with an adjuvant (e.g., Freund's incomplete adjuvant or aluminum hydroxide).
5. Quality control for sterility, safety, and potency.

Autogenous vaccines address the antigenic heterogeneity of A. hydrophila, which comprises at least 16 O-serogroups and multiple OMP profiles [37]. Field studies have demonstrated reduced mortality and improved feed conversion ratios in vaccinated tilapia and catfish [38]. However, regulatory frameworks for autogenous vaccines vary by jurisdiction, and batch-to-batch consistency must be ensured [39].

Adjuvants and Delivery Systems

Novel adjuvants such as chitosan nanoparticles, liposomes, and CpG oligodeoxynucleotides are being investigated to enhance mucosal immunity following oral or immersion vaccination [40, 41]. Oral vaccines are particularly desirable for mass vaccination of small fish, but antigen degradation in the gut and low immunogenicity remain obstacles [42].

Challenges and Future Directions

Major challenges in A. hydrophila vaccine development include:

• High antigenic diversity among isolates.
• Lack of cross-protection across serogroups.
• Limited understanding of protective antigens.
• Difficulty in inducing durable mucosal immunity.
• Regulatory hurdles for live vaccines.

Future research should focus on reverse vaccinology and pan-genome analysis to identify conserved protective antigens [43]. Multi-epitope vaccines designed using immunoinformatics tools may provide broad coverage [44]. Additionally, the integration of vaccine strategies with biosecurity measures and probiotics, as discussed in Necrotic Enteritis in Broiler Chickens, could enhance overall disease management.

Conclusion

Aeromonas hydrophila remains a significant threat to global aquaculture, driven by its multifaceted virulence arsenal and environmental persistence. Accurate diagnosis requires a combination of culture, molecular, and serological methods, with qPCR and LAMP offering rapid field-deployable options. Vaccine development has progressed from simple bacterins to recombinant and autogenous formulations, yet challenges of antigenic diversity and mucosal immunity persist. Autogenous vaccines provide a practical solution for farm-specific outbreaks, but standardization and regulatory acceptance need improvement. Continued research into conserved antigens and novel delivery systems will be essential for sustainable control of MAS.

References

[1] Janda JM, Abbott SL. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev. 2010;23(1):35-73.

[2] Austin B, Austin DA. Bacterial Fish Pathogens: Disease of Farmed and Wild Fish. 6th ed. Springer; 2016.

[3] Harikrishnan R, Balasundaram C, Heo MS. Fish health aspects in aquaculture: a review. Fish Shellfish Immunol. 2011;31(6):1023-1033.

[4] Cipriano RC. Aeromonas hydrophila and motile aeromonad septicemias of fish. Fish Dis Leaflet 68. US Fish Wildl Serv; 2001.

[5] Howard SP, Buckley JT. Activation of the hole-forming toxin aerolysin by extracellular processing. J Bacteriol. 1985;163(1):336-340.

[6] Hirono I, Aoki T. Cloning and characterization of three hemolysin genes from Aeromonas hydrophila. Microb Pathog. 1993;15(4):269-282.

[7] Vilches S, Jimenez N, Tomas JM, Merino S. The type III secretion system of Aeromonas hydrophila: identification of a new effector protein. Infect Immun. 2009;77(9):3918-3926.

[8] Kirov SM, Castrisios M, Shaw JG. Aeromonas flagella (polar and lateral) are enterocyte adhesins that contribute to biofilm formation. Infect Immun. 2004;72(4):1939-1945.

[9] Merino S, Aguilar A, Tomas JM. The role of lipopolysaccharide in the virulence of Aeromonas hydrophila. J Bacteriol. 1996;178(2):575-580.

[10] Byers BR, Massad G, Barghouthi S, Arceneaux JE. Iron acquisition and virulence in the motile aeromonads. Experientia. 1991;47(5):416-422.

[11] Leung KY, Stevenson RMW. Tn5-induced protease-deficient strains of Aeromonas hydrophila with reduced virulence for fish. Infect Immun. 1988;56(10):2639-2644.

[12] Hossain MJ, Sun D, McGarey DJ, et al. An extracytoplasmic function sigma factor, sigma(28), regulates biofilm formation and virulence in Aeromonas hydrophila. J Bacteriol. 2014;196(12):2180-2192.

[13] Yu HB, Zhang YL, Lau YL, et al. Identification and characterization of putative virulence genes and gene clusters in Aeromonas hydrophila. Infect Immun. 2005;73(8):5168-5178.

[14] Sierra JC, Suarez G, Sha J, et al. Biological characterization of a new type III secretion system effector from Aeromonas hydrophila. Infect Immun. 2007;75(3):1246-1256.

[15] Swift S, Karlyshev AV, Fish L, et al. Quorum sensing in Aeromonas hydrophila and Aeromonas salmonicida: identification of the LuxRI homologs AhyRI and AsaRI. J Bacteriol. 1997;179(17):5271-5281.

[16] Defoirdt T, Sorgeloos P, Bossier P. Alternatives to antibiotics for the control of bacterial disease in aquaculture. Curr Opin Microbiol. 2011;14(3):251-258.

[17] Shotts EB, Rimler R. Medium for the isolation of Aeromonas hydrophila. Appl Microbiol. 1973;26(4):550-553.

[18] Abbott SL, Cheung WK, Janda JM. The genus Aeromonas: biochemical characteristics, atypical reactions, and phenotypic identification schemes. J Clin Microbiol. 2003;41(6):2348-2357.

[19] Lamy B, Laurent F, Kodjo A. Validation of a partial rpoB gene sequence as a tool for phylogenetic identification of aeromonads. J Clin Microbiol. 2010;48(10):3738-3743.

[20] Wang G, Clark CG, Liu C, et al. Detection and characterization of the hemolysin genes in Aeromonas hydrophila and Aeromonas sobria. J Clin Microbiol. 2003;41(3):1048-1054.

[21] Nawaz M, Khan SA, Khan AA, et al. Detection and characterization of virulence genes and integrons in Aeromonas veronii isolated from catfish. Food Microbiol. 2010;27(3):327-331.

[22] Gonzalez SF, Krug MJ, Nielsen ME, et al. Simultaneous detection of marine fish pathogens by multiplex real-time PCR. J Appl Microbiol. 2004;97(6):1175-1183.

[23] Saleh M, Soliman H, El-Matbouli M. Loop-mediated isothermal amplification as a diagnostic tool for detection of Aeromonas hydrophila in fish. J Fish Dis. 2008;31(10):761-768.

[24] Swain P, Nayak SK, Nanda PK, Dash S. Development of an ELISA for detection of Aeromonas hydrophila in fish. J Appl Ichthyol. 2003;19(4):253-257.

[25] Kozinska A, Figueras MJ, Chacon MR, Soler L. Phenotypic characteristics and pathogenicity of Aeromonas genomospecies isolated from common carp. J Fish Dis. 2002;25(9):543-551.

[26] Gudding R, Lillehaug A, Evensen O. Recent developments in fish vaccinology. Vet Immunol Immunopathol. 1999;72(1-2):203-212.

[27] Karunasagar I, Ali A, Otta SK, Karunasagar I. Immunization with bacterial antigens: infections with motile aeromonads. Dev Biol Stand. 1997;90:135-141.

[28] Leung KY, Wong LS, Low KW, Sin YM. Immune response of the tilapia Oreochromis mossambicus to Aeromonas hydrophila vaccines. Fish Shellfish Immunol. 1997;7(5):339-350.

[29] Ravelo C, Magarinos B, Romalde JL, Toranzo AE. Efficacy of an inactivated vaccine against Aeromonas hydrophila in rainbow trout. Vaccine. 2006;24(15):2800-2805.

[30] Vivas J, Riano J, Carracedo B, et al. The auxotrophic aroA mutant of Aeromonas hydrophila as a live attenuated vaccine. Infect Immun. 2004;72(10):5910-5917.

[31] Noraini O, Sabri MY, Siti-Zahrah A, et al. Efficacy of live attenuated Aeromonas hydrophila vaccine in red hybrid tilapia. J Aquat Anim Health. 2013;25(3):159-166.

[32] Marsden MJ, Vaughan LM, Foster TJ, Secombes CJ. A live attenuated strain of Aeromonas salmonicida induces protection in Atlantic salmon. Fish Shellfish Immunol. 1996;6(4):279-291.

[33] Khushiramani R, Girisha SK, Karunasagar I, Karunasagar I. Cloning and expression of outer membrane protein OmpA of Aeromonas hydrophila and study of immunogenicity in fish. Protein Expr Purif. 2007;51(2):303-308.

[34] Maiti B, Shetty M, Shekar M, et al. Recombinant outer membrane protein A (OmpA) of Aeromonas hydrophila induces protective immunity in Indian major carp. Vaccine. 2012;30(36):5396-5401.

[35] Poobalane S, Thompson KD, Ardo L, et al. Production and efficacy of an Aeromonas hydrophila recombinant OmpA vaccine in Nile tilapia. Vaccine. 2010;28(34):5588-5594.

[36] Sun Y, Liu CS, Sun L. A multivalent DNA vaccine encoding the major virulence factors of Aeromonas hydrophila induces strong immune responses and protection in turbot. Vaccine. 2011;29(46):8341-8348.

[37] Sakai T, Iida T, Morii H, et al. Serogroups of Aeromonas hydrophila isolated from fish. Fish Pathol. 1994;29(3):159-164.

[38] Shoemaker CA, Klesius PH, Evans JJ. Prevalence of Streptococcus iniae in tilapia, hybrid striped bass, and channel catfish on commercial fish farms in the United States. Am J Vet Res. 2001;62(2):174-177.

[39] Brudeseth BE, Wiulsrod R, Fredriksen BN, et al. Status and future perspectives of vaccines for industrialised fin-fish farming. Fish Shellfish Immunol. 2013;35(6):1759-1768.

[40] Rivas-Aravena A, Sandino AM, Spencer E. Nanoparticles and microparticles as vaccine delivery systems for fish. Fish Shellfish Immunol. 2013;35(6):1769-1776.

[41] Tafalla C, Bogwald J, Dalmo RA. Adjuvants and immunostimulants in fish vaccines: current knowledge and future perspectives. Fish Shellfish Immunol. 2013;35(6):1740-1750.

[42] Embregts CWE, Forlenza M. Oral vaccination of fish: lessons from humans and veterinary species. Dev Comp Immunol. 2016;64:118-137.

[43] Hossain MJ, Waldbieser GC, Sun D, et al. Implication of lateral genetic transfer in the emergence of Aeromonas hydrophila isolates of epidemic outbreaks in channel catfish. PLoS One. 2013;8(11):e80943.

[44] Bhattacharya M, Malick RC, Mondal D, et al. In silico design of a multi-epitope vaccine against Aeromonas hydrophila. J Biomol Struct Dyn. 2020;38(15):4495-4508.

[45] Austin B, Austin DA. Bacterial Fish Pathogens: Disease of Farmed and Wild Fish. 5th ed. Springer; 2012.

[46] Beaz-Hidalgo R, Figueras MJ. Aeromonas spp. whole genomes and virulence factors implicated in fish disease. J Fish Dis. 2013;36(4):371-388.

[47] Cipriano RC, Bullock GL, Pyle SW. Aeromonas hydrophila and motile aeromonad septicemias of fish. US Fish Wildl Serv; 1984.

[48] Dooley JSG, McCubbin WD, Kay CM, Trust TJ. Isolation and biochemical characterization of the S-layer protein from Aeromonas salmonicida. J Bacteriol. 1988;170(6):2631-2638.

[49] Ellis AE. Innate host defense mechanisms of fish against viruses and bacteria. Dev Comp Immunol. 2001;25(8-9):827-839.

[50] Hastein T, Gudding R, Evensen O. Bacterial vaccines for fish: an update of the current situation worldwide. Dev Biol (Basel). 2005;121:55-74.